As of November 6, 2026, Trulieve Cannabis Corp. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 21, 2026 to June 12, 2026 (Form 8-K, June 12, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Trulieve Cannabis Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Trulieve Cannabis Corp. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-21 to 2026-06-12. Every row below is cited to the filing it comes from, and this page adds each new change as Trulieve Cannabis Corp. files it.
Also on the record for Trulieve Cannabis Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 8, 2026 | Stake report, Schedule 13G, by AdvisorShares Trust | 6.26% of the class | 5%+ stakes | Source |
| December 18, 2025 | Stake report, Schedule 13G, by Marex Securities Products Inc. | 5.8% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Trulieve Cannabis Corp. now and the warning signs.
Free to see. No signup.
Keep reading
More on Trulieve Cannabis Corp. and the records around it.
Trulieve Cannabis Corp. elsewhere on the record
Companies that share a holder
- Marex Securities Products Inc. also filed stake reports on 5 other companies: POET TECHNOLOGIES INC. (May 2026), APPLIED OPTOELECTRONICS, INC. (May 2026), AXT INC (May 2026)
- AdvisorShares Trust also filed stake reports on 8 other companies: Neuphoria Therapeutics Inc. (Oct 2026), PSYENCE BIOMEDICAL LTD. (Oct 2026), Silo Pharma, Inc. (Jul 2026)
Watch Trulieve Cannabis Corp.
Get an email when Trulieve Cannabis Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Trulieve Cannabis Corp.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Trulieve Cannabis Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Trulieve Cannabis Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-12 | Reported | not named in the filing | 8-K, 2026-06-12 | ||
| 2026-04-21 | Reported | not named in the filing | 8-K, 2026-04-21 |
New leaders reset buying decisions — get the Full Report on Trulieve Cannabis Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Trulieve Cannabis Corp., with the record behind each one.
Find candidates like senior executive at Trulieve Cannabis Corp.Every change, in the filing's words
Reported
On June 11, 2026 (the "Termination Date"), the Company and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the "Company") effective immediately.
- In connection with this termination, Mr. Pernell and the Company entered into a Separation Agreement and General Release, dated as of June l1, 2026 (the "Separation Agreement").
- Pursuant to the Separation Agreement, each of the Company and Mr. Pernell agreed to a mutual release of certain claims, and Mr. Pernell agreed not to, among other things, sell, grant, secure, pledge, or otherwise transfer, dispose of or monetize the Company's subordinate voting shares or other equity securities held in his name for a period of one year from the date of the Separation Agreement.
- Contingent upon Mr. Pernell's compliance with all the provisions of the Separation Agreement, he is entitled to (i) the quarterly performance bonus for the second quarter of fiscal year 2026 pursuant to the Company's customary executive bonus payment practices and (ii) be paid a prorated portion of the balance of the target performance bonus for fiscal year 2026 pursuant to the Company's customary executive bonus payment practices after 2026 earnings.
Reported
Mr. Beshears' decision not to stand for reelection to the Company's board of directors was not due to any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
- On April 15, 2026, Thad Beshears gave notice that he will not be standing for reelection to the board of directors at the annual meeting of the shareholders of Trulieve Cannabis Corp. (the "Company") to be held June 9, 2026.
- Mr. Beshears has been a director of the Company since 2015.
Tools for this story
Each opens in a new tab, filled in for Trulieve Cannabis Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.